ENZO BIOCHEM INC (ENZ)

US2941001024 - Common Stock

1.07  +0.01 (+0.94%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ENZO BIOCHEM INC

NYSE:ENZ (4/25/2024, 7:04:00 PM)

1.07

+0.01 (+0.94%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap54.82M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ENZ Daily chart

Company Profile

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. The company is headquartered in Farmingdale, New York and currently employs 179 full-time employees. The firm operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The firm is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The firm's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. The company has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Company Info

ENZO BIOCHEM INC

60 Executive Blvd

Farmingdale NEW YORK 10022

P: 15167555500

CEO: Elazar Rabbani

Employees: 179

Website: https://www.enzo.com/

ENZ News

News Image17 days ago - ChartmillTuesday's pre-market session: top gainers and losers

Get insights into the top gainers and losers of Tuesday's pre-market session.

News Imagea month ago - Enzo Biochem, Inc. Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update

FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.

News Image3 months ago - Enzo Biochem, Inc. Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
News Image3 months ago - Enzo Biochem, Inc. Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced...

News Image4 months ago - InvestorPlaceENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024

Enzo Biochem just reported results for the first quarter of 2024.

News Image4 months ago - BusinessInsiderENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the first quarter of 2024.Enz...

ENZ Twits

Here you can normally see the latest stock twits on ENZ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example